Europe and Northern America vs Philippines: Percentage of bloodstream infection due to methicillin-resistant
Europe and Northern America
8.0%
in 2022
Philippines
44.4%
in 2022
Europe and Northern America rank
14th
Philippines rank
15th
Percentage of bloodstream infection due to methicillin-resistant over time
- Europe and Northern America
- Philippines
How they compare
Philippines currently reports 44.4% against 8.0% in Europe and Northern America, a difference of 36.4%.
That makes Philippines's figure about 5.6 times Europe and Northern America's.
Across all 6 years both countries report, Philippines has been ahead every year.
Europe and Northern America ranks 14th and Philippines ranks 15th of 15 groups.
Philippines has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Europe and Northern America | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 14.2% | 54.8% | 40.6% | Philippines |
| 2020s | 8.5% | 44.9% | 36.4% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Europe and Northern America or Philippines?
- Philippines, at 44.4% against 8.0% in Europe and Northern America as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Europe and Northern America and Philippines?
- 36.4%, with Philippines ahead.
- How many years of comparable data are there for Europe and Northern America and Philippines?
- 6 years are reported by both, from 2017 to 2022.
- How do Europe and Northern America and Philippines rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Europe and Northern America ranks 14th and Philippines ranks 15th of 15 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.